|
Northern Europe Biotech News. Service for global professionals. Constantly updated news and information about Northern Europe Biotech.
Latest Northern Europe Biotech News
- The Middle East: Pharma's New Frontier 9 Nov 2009 17:35 GMT
... Jordan, Oman, Romania, Algeria, Yemen, Bahrain Kuwait, Saudi ... Germany, Belgium, Spain, Netherlands, Austria, Greece, Brazil, Finland, Portugal, Czech, Denmark, Switzerland, France, Liechtenstein, South Africa and Sri ...
- BUYINS.NET: GLAD, DCGN, EPM Expected To Be Lower Leading Up To Next Earnings Releases 9 Nov 2009 09:36 GMT
... Nov 09, 2009 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET ... of cancer. The company serves pharmaceutical companies, biotechnology firms, pharmacogenomics companies, government institutions, research consortia, ... in 1996 and is headquartered in Reykjavik, Iceland. Evolution Petroleum Corporation (NYSE: EPM) engages in the ...
- Genmab Announces Start of Ofatumumab Phase III Head to Head Study in DLBCL 9 Nov 2009 08:10 GMT
... COPENHAGEN, Denmark, Nov. 9, 2009 (GLOBE NEWSWIRE) -- Summary: Genmab ... for DLBCL. Genmab is a leading international biotechnology company focused on developing fully human antibody ...
- Kenyan Researcher Awarded for Efforts in Fighting Malaria 9 Nov 2009 01:34 GMT
... Every time Fredros Okumu spends his free time in ... companies from Kenya, South Africa, Uganda, Zambia, Finland, Italy, Netherlands, Sweden and the UK. Among the new winners are ...
- Researcher Awarded for Efforts in Fighting Malaria 9 Nov 2009 07:56 GMT
... Every time Fredros Okumu spends his free time in ... companies from Kenya, South Africa, Uganda, Zambia, Finland, Italy, Netherlands, Sweden and the UK. Among the new winners are ...
- Link Technologies inks first license to RiboTask's Unlocked Nucleic Acid (UNA) Monomers 9 Nov 2009 13:12 GMT
... The ISO 9001:2000 certified specialist oligonucleotide reagent manufacturer, Link ... (UNA) monomers under license from RiboTask ApS, Denmark. Under the terms of the agreement Link are ... About RiboTask ApS RiboTask is a Danish biotechnology company offering RNA oligonucleotides for research and ...
- Genmab initiates ofatumumab Phase III study in diffuse large B-cell lymphoma 9 Nov 2009 12:15 GMT
... Genmab Initiates Ofatumumab Phase III Study in Diffuse Large ... Large B-cell Lymphoma 9 November 2009 - Denmark-based biotechnology company Genmab A/S (CPH: GEN) said today ...
- Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 9 Nov 2009 19:10 GMT
... Royal Institute of Technology Adopts OriGene Over-Expression Lysates in ... today announced Royal Institute of Technology in Sweden has adopted its VERIFY Tagged Antigen(TM) (Over-expression Lysates) ... company dedicated to support academic, pharmaceutical and biotech companies in their research of gene functions ...
- Area biotech firms make pitches for funding 6 Nov 2009 06:50 GMT
... Area biotech firms make pitches for funding Four area ... Chalmers University of Technology in his native Sweden on a process for growing a cellulose material ...
- Lithuania's OTC pharmaceutical market to reach a value of LTL2.13bn by 2013 7 Nov 2009 07:57 GMT
... ) has announced the addition of the "Lithuania Pharmaceuticals and Healthcare Report Q4 2009" report ... in the CEE region, between Moldova and Latvia. In relation to the previous quarter, Lithuania ...
- Research and Markets: By 2013, The Value of Lithuania's Prescription and Over-The-Counter (OTC) Markets is to Reach a Value of LTL2.13bn 6 Nov 2009 15:11 GMT
... Research and Markets: By 2013, The Value of Lithuania's Prescription and Over-The-Counter (OTC) Markets is to ... in the CEE region, between Moldova and Latvia. In relation to the previous quarter, Lithuania ...
- Research and Markets: By 2013, The Value of Lithuania's Prescription and Over-The-Counter (OTC) Markets is to Reach a Value of LTL2.13bn (BIZ) 6 Nov 2009 15:17 GMT
... and Healthcare Report provides industry professionals and strategists, corporate ... with independent forecasts and competitive intelligence on Lithuania's pharmaceuticals and healthcare industry. BMI calculates that ... in the CEE region, between Moldova and Latvia. In relation to the previous quarter, Lithuania ...
- Research and Markets: By 2013, The Value of Lithuania's Prescription and Over-The-Counter (OTC) Markets is to Reach a Va 6 Nov 2009 15:33 GMT
... ) has announced the addition of the " Lithuania Pharmaceuticals and Healthcare Report provides industry professionals ... in the CEE region, between Moldova and Latvia. In relation to the previous quarter, Lithuania ...
- Research and Markets: By 2013, The Value of Lithuania's Prescription and Over-The-Counter (OTC) Markets is to Reach a Value of LTL2.13bn 6 Nov 2009 15:48 GMT
... Research and Markets: By 2013, The Value of Lithuania's Prescription and Over-The-Counter (OTC) Markets is to ... in the CEE region, between Moldova and Latvia. In relation to the previous quarter, Lithuania ...
- The creation of a new niche specialty pharmaceutical company focused on rare diseases - with strong cash flow generation 5 Nov 2009 09:25 GMT
... Biovitrum and Swedish Orphan will be combined forming Swedish Orphan ... Transaction). Biovitrum's head office is located in Sweden and the share is listed on the ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
|
a digital news provider
>
All Northern Europe News sections
latimes.com:
cnn.com:
nytimes.com:
reuters.com:
bbc.co.uk:
wsj.com: